ETON Similar Chart Price Prediction
The price of ETON is predicted to go up 1.85%, based on the high correlation periods with GEO. The similarity of these two price pattern on the periods is 94.86%.
ETON
GEO
Up: 1.85%Similarity: 94.86%
ETON Revenue Forecast
ETON EPS Forecast
ETON FAQs
What is ETON revenue forecast for next quarter？
ETON Analyst's Forecast
Madison El-Saadi
B. Riley Securities
Strong Buy
2025-01-10
Price Target
$21
Upside
+56.25%
B. Riley initiated coverage of Eton Pharmaceuticals with a Buy rating and $21 price target. The firm believes Eton is approaching a revenue inflection point in 2025, driven by Increlex and ET-400, which may result in profitability in 2025 with ensuing growing positive cash flow. Eton is a specialty pharmaceutical company in the ultra-rare pediatric endocrinology and metabolic genetics space focused on acquiring under-invested products with an indication-specific value proposition and late-stage candidates, the analyst tells investors in a research note.
Chase Knickerbocker
Craig-Hallum
Strong Buy
2024-10-28
Price Target
$10 → $15
Upside
+74.01%
Chase Knickerbocker
Craig-Hallum
Strong Buy
2024-10-04
Price Target
$8 → $10
Upside
+29.53%
